September 22, 2021
Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer
0 Comments5 Minutes
January 4, 2018
Belgian Biotech Hits ‘Fast Forward’ on Multiple Sclerosis Therapies
0 Comments2 Minutes
January 4, 2018
Rewind Therapeutics Secures 15.2 M EURO to Develop Novel Remyelination Therapies
1 Comment6 Minutes